Financial Data and Key Metrics Changes - For Q2 2025, the company generated revenues of approximately 41.8million,aslightincreaseof100,000 or about 0.3% from 41.7millioninthesameperiodlastyear[7][27]−Grossmarginincreasedto18.57.7 million from 6.3millioninthesamequarteroffiscal2024[7][30]−Thenetlossforthequarterwas8 million or 0.14pershare,comparedtoanetlossof4 million or 0.07pershareintheprioryear[31]BusinessLineDataandKeyMetricsChanges−Thenicotinebusinessaccountedfor31 million of overall revenue in Q2 2025, performing in line with expectations [9] - Revenue from Europe was approximately 24million,representingstronggrowthof8.3 million or 53.2% year-over-year [28] - North America saw revenues of approximately 10.9million,adeclineof9 million or 45.3% compared to the previous year, primarily due to decreased sales of cannabis vaping products [28] - Asia Pacific revenues were approximately 3.6million,adeclineof2.4 million or 39.6% year-over-year [28] - Revenue from Africa increased to 2.7million,up2.6 million from the same period last year, attributed to the launch in South Africa [28] Market Data and Key Metrics Changes - The South African tobacco products market is projected to grow annually by over 5% between now and 2029, presenting significant opportunities for the company [13] - The company has established a presence in over 500 retail locations across South Africa and Nigeria, with plans to expand to over 2,000 stores in the next six months [11] Company Strategy and Development Direction - The company is focused on international growth and enhancing financial stability through a better quality of customer portfolio and revenue [6][8] - A stock repurchase program of up to 10millionhasbeenauthorized,reflectingtheboard′sconfidenceinthecompany′slong−termvision[17]−Thecompanyispreparingtolaunchitsage−gatingGMASproductsintheUKmarketinthefirsthalfofcalendar2025,demonstratingcommitmenttoresponsiblemarketentry[15]Management′sCommentsonOperatingEnvironmentandFutureOutlook−Managementexpressedoptimismabouttheongoingprogressinsalesandinternationalexpansion,particularlyinAfricaandMalaysia[10][14]−ThecompanyanticipatesthattheregulatorylandscapeintheUKwillfavoritsopensystemproductsasdisposablevapedevicesaresettobebanned[47][48]−ManagementacknowledgedthechallengesposedbypotentialtariffincreasesonimportsfromChinabutbelievesthecompanyiswell−positionedtomitigatetheserisksthroughitsmanufacturingoperationsinMalaysia[60]OtherImportantInformation−Thecompanyhasimplementedcost−savinginitiativesexpectedtogenerateover8 million annually, aimed at optimizing its cost structure [24] - The company is on track to submit the age-gating component of PMTA in April 2025, which could open significant revenue opportunities [21][69] Q&A Session Summary Question: Update on cannabis partnerships and pipeline - Management indicated that the cannabis business has pivoted towards larger MSO customers, with three partnerships already established, which could provide roughly one-third of revenue in the near future [40][42] Question: Performance in Europe - Management noted that the UK market is shifting towards open systems due to regulatory changes, which positions the company favorably [46][48] Question: Rationale behind the stock buyback program - The stock buyback program is designed to provide flexibility over a 24-month period, with expectations for cash flow to improve despite some one-time expenses related to cost-saving initiatives [52][54][56] Question: Impact of U.S. tariffs and regulations - Management expects tariff increases on Chinese products but believes the company will benefit from tighter border controls on illegal products [60][62] Question: Modular PMTA opportunity - The PMTA component represents a unique approach to addressing the flavored e-cigarette market, with potential licensing revenue opportunities from other manufacturers [68][70]